Cynthia Collins has joined the board of directors of Editas Medicine. Most recently, she was the CEO of Human Longevity. Prior to that, she was CEO/GM of General Electric's Healthcare Cell Therapy Business, Lab Businesses, and Clarient Diagnostics. Before that, she was president and CEO of GenVec, and prior to that, group vice president of the Cellular Analysis Business of Beckman Coulter. Collins holds a BS degree in microbiology from the University of Illinois, Urbana, and an MBA from the University of Chicago Booth School of Business.